$35.03
+4.39 (+14.33%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
-29.3% upside
Low Target
$14.60
Average Target
$24.77
High Target
$27.54
Current Price
$35.03
Current
$35.03
$35.03
Target
$24.77
$24.77
$14.60
$24.77 avg
$27.54
Scenario Analysis
Bear Case
$14.60
-58.3%
Low target
Base Case
$24.77
-29.3%
Avg target
Bull Case
$27.54
+-21.4%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$33.60
4.3% from high
52-Week Low
$10.38
+237.6% from low
Target vs 52W High
$24.77
-26.3% vs high
Next Earnings Report
Nov 9, 2026
2d
until earnings
EPS Est: $-0.59
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +115.6% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -42.4% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.4% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.8% |